Molecular & Cellular Proteomics · 2016 · 48 citations · 35 references
Life SciencesNeurologyNeuroscienceMass Spectrometric AnalysisNeurodegenerationProteomicsClinical ProteomicsMass Spectrometry Data AnalysisMass Spectrometry-based ProteomicsQuantitative ProteomicsCurated Data SetsData Analysis AlgorithmsDisease ProteomicsMass Spectral Data AnalysisMass Spectrometry ProteomicsProteomic Data AnalysisQuantitative Proteomics WorkflowsReference Data Sets
The rapidly growing number of biomedical studies supported by mass spectrometry based quantitative proteomics data has made it increasingly difficult to obtain an overview of the current status of the research field. A better way of organizing the biomedical proteomics information from these studies and making it available to the research community is therefore called for. In the presented work, we have investigated scientific publications describing the analysis of the cerebrospinal fluid proteome in relation to multiple sclerosis, Parkinson's disease and Alzheimer's disease. Based on a detailed set of filtering criteria we extracted 85 data sets containing quantitative information for close to 2000 proteins. This information was made available in CSF-PR 2.0 (http://probe.uib.no/csf-pr-2.0), which includes novel approaches for filtering, visualizing and comparing quantitative proteomics information in an interactive and user-friendly environment. CSF-PR 2.0 will be an invaluable resource for anyone interested in quantitative proteomics on cerebrospinal fluid.
35
The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods
Clifford R. Jack, Matt A. Bernstein, Nick C. Fox et al. · Journal of Magnetic Resonance Imaging · 2008 · 4.4K citations · Full text
Medicine, Neurology, Neuroscience +17
Dynamics of brain-derived proteins in cerebrospinal fluid
Hansotto Reiber · Clinica Chimica Acta · 2001 · 508 citations